Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B

Open access

Abstract

Hemophilia B is an X-linked coagulopathy caused by absence of functional coagulation factor IX (F.IX). Previously, we established an experimental basis for gene transfer as a method of treating the disease in mice and hemophilic dogs through intramuscular injection of a recombinant adeno-associated viral (rAAV) vector expressing F.IX. In this study we investigated the safety of this approach in patients with hemophilia B. In an open-label dose-escalation study, adult men with severe hemophilia B (F.IX < 1%) due to a missense mutation were injected at multiple intramuscular sites with an rAAV vector. At doses ranging from 2 x 10(11) vector genomes (vg)/kg to 1.8 x 10(12) vg/kg, there was no evidence of local or systemic toxicity up to 40 months after injection. Muscle biopsies of injection sites performed 2 to 10 months after vector administration confirmed gene transfer as evidenced by Southern blot and transgene expression as evidenced by immunohistochemical staining. Pre-existing high-titer antibodies to AAV did not prevent gene transfer or expression. Despite strong evidence for gene transfer and expression, circulating levels of F.IX were in all cases less than 2% and most were less than 1%. Although more extensive transduction of muscle fibers will be required to develop a therapy that reliably raises circulating levels to more than 1% in all subjects, these results of the first parenteral administration of rAAV demonstrate that administration of AAV vector by the intramuscular route is safe at the doses tested and effects gene transfer and expression in humans in a manner similar to that seen in animals.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2002-10-3296

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 78 references

Research works printed but not linked: 5

  1. Soucie, 2000, Blood, 96, 437
  2. Bond, 1998, Seminars in hematology, 35, 11
  3. 1989, MOLECULAR CLONING, 9, 9
  4. Bray, 1994, Blood, 83, 2428
  5. 1997, Blood, 90(suppl), 418b

Cited by

See all 749

Metadata

Authors
Manno, C. S., Chew, A. J., Hutchison, S., Larson, P. J., Herzog, R. W., Arruda, V. R., Tai, S. J., Ragni, M. V., Thompson, A., Ozelo, M., Couto, L. B., Leonard, D. G. B., Johnson, F. A., McClelland, A., Scallan, C., Skarsgard, E., Flake, A. W., Kay, M. A., High, K. A., & Glader, B.
Affiliations
Children's Hospital of Philadelphia (US)
Corresponding author
Manno, C. S.
Venue
Blood
Published
2003-04-15
Volume
101
Issue
8
Pages
2963-2972
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2130515212
Cited by
749
References
78
Citations by year
2026: 6 · 2025: 12 · 2024: 24 · 2023: 12 · 2022: 15 · 2021: 16 · 2020: 19 · 2019: 21 · 2018: 18 · 2017: 25 · 2016: 21 · 2015: 38 · 2014: 33 · 2013: 44 · 2012: 41
FWCI
31.88
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hl071518-05, 5r01hl061921-02)
  • National Heart, Lung, and Blood Institute (P01HL64190, R01 HL71518, R01 HL61921, U01HL066948, P01HL064190, U01-HL66948)
Topics
  • Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
hemophilia B, factor IX, adeno-associated virus vectors, gene therapy, intramuscular injection, skeletal muscle, dose escalation, safety, transduction, missense mutations
MeSH terms
Dependovirus, Adult, Aged, Biopsy, Hemophilia B, Combined Modality Therapy, Factor IX, Feasibility Studies, Genetic Vectors, Hepatitis, Viral, Human, Humans, Injections, Intramuscular, Male, Recombinant Fusion Proteins, Safety, Genetic Therapy, HIV Infections, Muscle, Skeletal, Amino Acid Substitution, Mutation, Missense

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. https://app.cochat.ai/papers/10.1182/blood-2002-10-3296
The paper
Manno, C. S., Chew, A. J., Hutchison, S., Larson, P. J., Herzog, R. W., Arruda, V. R., Tai, S. J., Ragni, M. V., Thompson, A., Ozelo, M., Couto, L. B., Leonard, D. G. B., Johnson, F. A., McClelland, A., Scallan, C., Skarsgard, E., Flake, A. W., Kay, M. A., High, K. A., & Glader, B. (2003). AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood. https://doi.org/10.1182/blood-2002-10-3296

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.